(0.73%) 5 119.25 points
(0.11%) 38 331 points
(0.87%) 17 720 points
(0.78%) $84.22
(-6.59%) $1.530
(0.56%) $2 355.70
(0.74%) $27.56
(0.49%) $925.00
(0.14%) $0.933
(0.39%) $10.99
(0.00%) $0.799
(-0.74%) $91.49
Live Chart Being Loaded With Signals
Zeria Pharmaceutical Co., Ltd., together with its subsidiaries, manufactures, sells, imports, and exports pharmaceuticals, non-pharmaceutical products, veterinary pharmaceuticals, agricultural chemicals, industrial chemicals, and reagents in Japan and internationally...
Stats | |
---|---|
Today's Volume | 31 400.00 |
Average Volume | 74 768.00 |
Market Cap | 90.76B |
EPS | ¥0 ( 2024-01-31 ) |
Next earnings date | ( ¥0 ) 2024-05-09 |
Last Dividend | ¥22.00 ( 2023-03-30 ) |
Next Dividend | ¥0 ( N/A ) |
P/E | 10.51 |
ATR14 | ¥2.73 (0.13%) |
Volume Correlation
Zeria Pharmaceutical Co., Correlation
10 Most Positive Correlations |
---|
10 Most Negative Correlations |
---|
Did You Know?
Correlation is a statistical measure that describes the relationship between two variables. It ranges from -1 to 1, where -1 indicates a perfect negative correlation (as one variable increases, the other decreases), 1 indicates a perfect positive correlation (as one variable increases, the other increases), and 0 indicates no correlation (there is no relationship between the variables).
Correlation can be used to analyze the relationship between any two variables, not just stocks. It's commonly used in fields such as finance, economics, psychology, and more.
Zeria Pharmaceutical Co., Correlation - Currency/Commodity
Zeria Pharmaceutical Co., Financials
Annual | 2022 |
Revenue: | ¥68.38B |
Gross Profit: | ¥49.49B (72.37 %) |
EPS: | ¥140.26 |
FY | 2022 |
Revenue: | ¥68.38B |
Gross Profit: | ¥49.49B (72.37 %) |
EPS: | ¥140.26 |
FY | 2022 |
Revenue: | ¥59.53B |
Gross Profit: | ¥42.15B (70.80 %) |
EPS: | ¥87.76 |
FY | 2021 |
Revenue: | ¥55.43B |
Gross Profit: | ¥39.63B (71.50 %) |
EPS: | ¥67.72 |
Financial Reports:
No articles found.
Zeria Pharmaceutical Co., Dividends
(Q3/22) | (Q4/22) | (Q1/23) | (Q2/23) | (Q3/23) | (Q4/23) | (Q1/24) | (Q2/24) | (Q3/24) | (Q4/24) |
¥18.00 (N/A) |
¥0 (N/A) |
¥22.00 (N/A) |
¥0 (N/A) |
¥0 (N/A) |
¥0 (N/A) |
¥0 (N/A) |
¥0 (N/A) |
¥0 (N/A) |
¥0 (N/A) |
Very Unsafe
High risk of being cut
Unsafe
Heightened risk of being cut
Borderline
Moderate risk of being cut
Safe
Unlikely to be cut
Very Safe
Very unlikely to be cut
First Dividend | ¥7.27 | 2001-03-27 |
Last Dividend | ¥22.00 | 2023-03-30 |
Next Dividend | ¥0 | N/A |
Payout Date | 0000-00-00 | |
Next Payout Date | N/A | |
# dividends | 46 | -- |
Total Paid Out | ¥532.64 | -- |
Avg. Dividend % Per Year | 0.00% | -- |
Score | 3.84 | -- |
Div. Sustainability Score | 10.00 | |
Div.Growth Potential Score | 5.56 | |
Div. Directional Score | 7.95 | -- |
Year | Amount | Yield |
---|
The company's strong Dividend Sustainability Score (DSS) indicates its robust capacity to uphold current dividend levels. However, its Dividend Growth Potential Score (DGPS) is only moderate, indicating limited growth potential. In summary, the company provides a promising overall dividend outlook, balancing both sustainability and growth potential.
Symbol | Title | Last dividend | Frequency | Years Dividend | Yearly Dividend | Score |
---|---|---|---|---|---|---|
8544.T | Ex Dividend Knight | 2023-09-28 | Semi-Annually | 0 | 0.00% | |
7868.T | Ex Dividend Junior | 2023-09-28 | Sporadic | 0 | 0.00% | |
7012.T | No Dividend Player | 2023-09-28 | Annually | 0 | 0.00% | |
6361.T | Ex Dividend Knight | 2023-12-28 | Semi-Annually | 0 | 0.00% | |
5232.T | Ex Dividend Knight | 2023-09-28 | Semi-Annually | 0 | 0.00% | |
4323.T | Ex Dividend Knight | 2024-03-28 | Annually | 0 | 0.00% | |
3488.T | Ex Dividend Junior | 2023-08-30 | Semi-Annually | 0 | 0.00% | |
2726.T | Ex Dividend Junior | 2024-02-28 | Annually | 0 | 0.00% | |
9616.T | Ex Dividend Knight | 2023-09-28 | Semi-Annually | 0 | 0.00% | |
8155.T | Ex Dividend Knight | 2023-05-30 | Semi-Annually | 0 | 0.00% |
Ratio | Actual Value | Weight | Normalized Value | Score | Range |
---|---|---|---|---|---|
netProfitMarginTTM | 0.116 | 1.500 | 7.68 | 10.00 | [0 - 0.5] |
returnOnAssetsTTM | 0.0564 | 1.200 | 8.12 | 9.74 | [0 - 0.3] |
returnOnEquityTTM | 0.121 | 1.500 | 9.77 | 10.00 | [0.1 - 1] |
payoutRatioTTM | 0 | -1.000 | 0 | 0 | [0 - 1] |
currentRatioTTM | 1.086 | 0.800 | 9.57 | 7.66 | [1 - 3] |
quickRatioTTM | 0.787 | 0.800 | -0.0759 | -0.0607 | [0.8 - 2.5] |
cashRatioTTM | 0.350 | 1.500 | 9.17 | 10.00 | [0.2 - 2] |
debtRatioTTM | 0.331 | -1.500 | 4.48 | -6.73 | [0 - 0.6] |
interestCoverageTTM | 23.81 | 1.000 | 2.29 | 2.29 | [3 - 30] |
operatingCashFlowPerShareTTM | 313.62 | 2.00 | 10.00 | 10.00 | [0 - 30] |
freeCashFlowPerShareTTM | 313.62 | 2.00 | 10.00 | 10.00 | [0 - 20] |
debtEquityRatioTTM | 0.646 | -1.500 | 7.42 | -10.00 | [0 - 2.5] |
grossProfitMarginTTM | 0.739 | 1.000 | 1.016 | 1.016 | [0.2 - 0.8] |
operatingProfitMarginTTM | 0.133 | 1.000 | 9.33 | 9.33 | [0.1 - 0.6] |
cashFlowToDebtRatioTTM | 0.273 | 1.000 | 9.60 | 9.60 | [0.2 - 2] |
assetTurnoverTTM | 0.487 | 0.800 | -0.0854 | -0.0683 | [0.5 - 2] |
Total Score | 10.34 |
Ratio | Actual Value | Weight | Normalized Value | Score | Range |
---|---|---|---|---|---|
peRatioTTM | 10.49 | 1.000 | 9.04 | 0 | [1 - 100] |
returnOnEquityTTM | 0.121 | 2.50 | 9.85 | 10.00 | [0.1 - 1.5] |
freeCashFlowPerShareTTM | 313.62 | 2.00 | 10.00 | 10.00 | [0 - 30] |
dividendYielPercentageTTM | 2.14 | 1.500 | 10.00 | 0 | [0 - 0.4] |
operatingCashFlowPerShareTTM | 313.62 | 2.00 | 10.00 | 10.00 | [0 - 30] |
payoutRatioTTM | 0 | 1.500 | 0 | 0 | [0 - 1] |
pegRatioTTM | 0.366 | 1.500 | -0.891 | 0 | [0.5 - 2] |
operatingCashFlowSalesRatioTTM | 0.185 | 1.000 | 7.87 | 0 | [0.1 - 0.5] |
Total Score | 5.56 |
Zeria Pharmaceutical Co.,
Zeria Pharmaceutical Co., Ltd., together with its subsidiaries, manufactures, sells, imports, and exports pharmaceuticals, non-pharmaceutical products, veterinary pharmaceuticals, agricultural chemicals, industrial chemicals, and reagents in Japan and internationally. It also provides cosmetics, health foods, alcoholic beverages, soft drinks, food additives, livestock feed, hygienic goods, medical devices, health equipment, hygiene facilities and equipment, beauty appliances, and measuring and analytical equipment. The company offers products in the gastrointestinal field, including therapeutic agents for functional dyspepsia, ulcerative colitis, Crohn's disease, and gastritis and ulcers; zinc containing anti-ulcerants; oral bowel cleansing agents; laxatives; therapeutic agents for hypophosphatemia; long-acting calcium channel blockers; oral NSAID; anti-leukopenia after radiotherapy products; sclerosing agent for varicose veins; anti-inflammatory topical blood circulation enhancers; non-steroidal anti-inflammatory ophthalmic solutions; absorbable topical hemostat products; and proton pump inhibitors. In addition, it offers consumer healthcare products, such as nutritional health drugs, cold remedies, ophthalmic solutions, anti-inflammatory/analgesics, hemorroidal remedies, dermal remedies, quasi-drugs/cosmetics, nutrient tonics, and food for specified health uses. The company was formerly known as Zeria Yakusho Kenkyusho Co., Ltd. and changed its name to Zeria Pharmaceutical Co., Ltd. in May 1970. Zeria Pharmaceutical Co., Ltd. was founded in 1955 and is headquartered in Tokyo, Japan.
About Live Signals
The live signals presented on this page help determine when to BUY or SELL NA. The signals have upwards of a 1-minute delay; like all market signals, there is a chance for error or mistakes.
The live trading signals are not definite, and getagraph.com hold no responsibility for any action taken upon these signals, as described in the Terms of Use. The signals are based on a wide range of technical analysis indicators